MedCity Influencers

ObamaCare and tax evasion

The Affordable Care Act (aka ObamaCare) may help reduce tax evasion, especially in states that don’t expand Medicaid eligibility. That’s because people whose projected income is between 1x and 4x the poverty level will be eligible for federal subsidies to purchase insurance on the new marketplaces (also called exchanges). There’s an incentive to report more […]

The Affordable Care Act (aka ObamaCare) may help reduce tax evasion, especially in states that don’t expand Medicaid eligibility. That’s because people whose projected income is between 1x and 4x the poverty level will be eligible for federal subsidies to purchase insurance on the new marketplaces (also called exchanges). There’s an incentive to report more income in order to be eligible for subsidies.

Kaiser Health News (In states that don’t expand Medicaid, some of the uninsured may still get help) doesn’t discuss the tax compliance issue directly, but does note that there’s a potential strategy for people to estimate their incomes optimistically in order to qualify for subsidies.

I’ve seen anecdotal evidence of this phenomenon in Massachusetts, since RomneyCare was instituted. Some babysitters and other informal workers started asking their employers for letters stating their hours and wages in order to qualify for subsidized insurance here. It may or may not have made economic sense for these workers to start declaring income, but it gave one more push toward getting on the books and going legit.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.